ARIAD Pharma (ARIA) Tops Q1 EPS by 3c; Revises Certain FY16 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| Ariad Pharmaceuticals, Inc. (NYSE: ARIA) | Delayed: 23.03 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.03 | 52 Week High | $14.34 | |||
| Open | $23.03 | 52 Week Low | $4.37 | |||
| Day High | $23.03 | P/E | N/A | |||
| Day Low | $23.03 | EPS | $-1.45 | |||
| Volume | 1 | |||||
